Press-release for stocks related to pharma

Prices are updated after-hours

tags : Pharma crawled time : 06:00

save search

Zealand Pharma Announces Financial Results for the Full Year 2023
Published: 2024-02-27 (Crawled : 06:00) - globenewswire.com
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -6.76% | O: -0.94% H: 0.0% C: 0.0%
pharma year financial results

Quality, Efficiency, and Accuracy Targeted by Rottendorf Pharma GmbH with Adoption of FactoryTalk PharmaSuite® MES from Rockwell Automation
Published: 2024-01-16 (Crawled : 06:00) - prnewswire.com
ROK | News | $273.5 -1.85% 0.0% 1.1M

Producer Manufacturing

| -7.6% | O: -0.54% H: 0.0% C: -1.51%
pharmasuite pharma

Zealand Pharma Announces Financial Results for the First Nine Months of 2023
Published: 2023-11-09 (Crawled : 06:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 1.4K

Health Technology

| 2.23% | O: 1.08% H: 0.02% C: 0.02%
SNY | News | $45.395 -1.55% -1.58% 4.4M

Health Technology

| -0.63% | O: 0.9% H: 0.0% C: 0.0%
pharma financial results

Verona Pharma to Report Third Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-10-19 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| 19.35% | O: -0.52% H: 3.8% C: -0.82%
pharma report update financial results

Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek
Published: 2023-10-17 (Crawled : 06:00) - globenewswire.com
ZEAL | $17.59 1.21% -4.21%

Health Technology

| Email alert Add to watchlist
zp8396 obesityweek pharma

Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023
Published: 2023-10-06 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| 6.83% | O: -0.33% H: 2.26% C: -0.07%
pharma update commercialization

Verona Pharma to Present Additional Analyses of Positive Phase 3 ENHANCE Studies in COPD at CHEST 2023
Published: 2023-10-03 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| 4.07% | O: -0.52% H: 3.7% C: -0.19%
pharma positive copd

Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation
Published: 2023-09-26 (Crawled : 06:00) - prnewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M

Health Technology

| 36.65% | O: 1.81% H: 0.2% C: -1.07%
pharma series therapy

Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD
Published: 2023-09-11 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| -18.11% | O: 0.92% H: 2.37% C: -2.17%
fda pharma drug treatment application copd

Verona Pharma to Present Additional Analysis of Phase 3 ENHANCE-1 Study in COPD at ERS International Congress 2023
Published: 2023-09-06 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| -17.48% | O: 0.31% H: 2.15% C: -1.53%
pharma congress international copd study

Christina Ackermann Joins Verona Pharma as Non-Executive Director
Published: 2023-08-31 (Crawled : 06:00) - globenewswire.com
OCS | $11.81 -0.76% -0.76% 57K

n/a

| -10.53% | O: 0.98% H: 0.52% C: -2.46%
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| -12.97% | O: 0.7% H: 5.96% C: 4.29%
pharma

Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism
Published: 2023-08-30 (Crawled : 06:00) - globenewswire.com
NVO | $122.75 -1.43% 0.0% 2.8M

Health Technology

| 30.83% | O: -0.72% H: 0.36% C: -0.49%
fda pharma review designation

Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-03 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| -23.33% | O: 0.0% H: 6.48% C: -4.57%
pharma update financial results

Verona Pharma to Present at 43rd Annual Canaccord Growth Conference
Published: 2023-07-26 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| -18.93% | O: -0.76% H: 3.4% C: 2.44%
pharma conference growth

Verona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate Update
Published: 2023-07-20 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| -23.26% | O: 0.38% H: 0.96% C: 0.52%
pharma report update financial results

Verona Pharma Announces Publication of Phase 3 ENHANCE Data in the American Journal of Respiratory and Critical Care Medicine
Published: 2023-06-28 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| -20.38% | O: 0.3% H: 3.3% C: 2.37%
pharma respiratory publication care

Verona Pharma Submits New Drug Application to US FDA for Ensifentrine for the Maintenance Treatment of COPD
Published: 2023-06-27 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology

| -22.0% | O: 1.55% H: 0.0% C: -3.53%
fda pharma drug treatment application copd

Verona Pharma to Present at Jefferies Healthcare Conference
Published: 2023-05-24 (Crawled : 06:00) - globenewswire.com
VRNA | $16.1 -1.83% -1.86% 490K

Health Technology